Entecavir was more effective than lamivudine in HbeAg-positive chronic hepatitis B

Reichen, Jürg (2006). Entecavir was more effective than lamivudine in HbeAg-positive chronic hepatitis B. ACP journal club, 145(1), p. 18. Philadelphia, Pa.: American College of Physicians

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Service Sector > Institute of Clinical Pharmacology and Visceral Research [discontinued]

UniBE Contributor:

Reichen, Jürg

ISSN:

1056-8751

ISBN:

16813366

Publisher:

American College of Physicians

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:45

Last Modified:

06 Dec 2013 13:41

PubMed ID:

16813366

URI:

https://boris.unibe.ch/id/eprint/18554 (FactScience: 746)

Actions (login required)

Edit item Edit item
Provide Feedback